Cardinal Health(CAH)

Focus: Cardinal Health is a $226.8B healthcare services and distribution company headquartered in Dublin, Ohio, serving pharmaceutical manufacturers, healthcare providers, and patients across the supply chain. As a publicly traded enterprise (NYSE: CAH) with 10,000+ employees, it operates at massive scale in pharmaceutical distribution, specialty care, and medical device logistics.

Profile data last refreshed 13h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

10001+

Open Jobs

743+1454 this month

Hot — 2203 jobs added in 30d

Net +1454 (2203 new, 749 removed). Aggressive expansion phase.

Should You Work at Cardinal Health?

AI assessment

Best for supply chain, regulatory, quality, and commercial professionals seeking stable, growth-stage operations roles in a $226B public company; poor fit for research scientists and drug development specialists seeking pipeline exposure.

Why Work Here

402 active job openings signal sustained hiring across supply chain (156 roles), engineering (46), and commercial (40) — opportunity-rich for operations and logistics professionals.

Data completeness

5/9 — Partial

Company HealthStrong

Pipeline

Mid-stage

1 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Revenue

$226.8B

Pipeline & Clinical Trials

Preoperative MRSA screening

Methicillin-resistant Staphylococcus Aureus Infection

N/A

Pain education with follow up encounters

Pain

N/A

Clinical Trials (1)

Help build intelligence for Cardinal Health

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Revenue growing 11% YoY ($205B→$226.8B) with strengthened cash position ($3.9B) and profitability recovery (net income +158% YoY to $852M) indicate financial stability and reinvestment capacity.

Hybrid pipeline exposure (medical devices like Mynx vascular closure, diagnostic imaging agents, and oncology support programs) offers career paths in regulatory affairs (14 open roles), quality assurance (19), and clinical operations.

Watch Out For

Low R&D intensity and modest pipeline activity (17 trials, mostly Phase 2) mean limited drug development career depth — this is fundamentally a distribution and services company, not a discovery engine.
Supply chain and manufacturing dominate hiring (189 of 546 roles); traditional pharma research, medical writing, and data science roles are minimal (2-2-2 openings respectively), signaling career ceilings in scientific tracks.

Generated by Claude from Cardinal Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

NCT03306147Negating Opioid and Pain Actively Through Intervention

N/A

MynxGrip

Endovascular

N/A

Simple Suppers

Childhood Obesity

N/A

Clinical Trials (1)

NCT02923050Simple Suppers Scale-up (S3)

N/A

DSMP through a Mobile Applications

Hypertension

N/A

Clinical Trials (1)

NCT05263726The Effect of a Disease Self-management Program Through a Mobile Applications for Patients With Hypertension

N/A

The Pediatric Anesthesia Quality Improvement Project

Surgery

N/A

Intermittent Pneumatic Compression

Hemodynamics

N/A

Clinical Trials (1)

NCT05945186Design Validation Hemodynamic Study of New Kendall SCD SmartFlow Compression System

N/A

Medication reconciliation completed by a RN, CPhT, or RPh

Medication Reconciliation

N/A

Clinical Trials (1)

NCT01065675Medication Histories Conducted by Nurses (RNs), Pharmacy Techs (CPhTs) & Pharmacists (RPhs)

N/A

Pembrolizumab

Oropharyngeal Squamous Cell Carcinoma

N/A

Clinical Trials (1)

NCT06771674Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma

N/A

99m Tc-TM

Breast Cancer

N/A

Clinical Trials (1)

NCT05236387Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection

N/A

PCSMP

Hypertensive Nephropathy

N/A

Clinical Trials (1)

NCT04633993Effectiveness of Implementation of a Patient-centered Self-management Program in Patients With Hypertensive Nephropathy

N/A

Lymphoseek plus Vital Blue Dye

Endometrial Cancer

PHASE_1

Clinical Trials (1)

NCT02589366Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium

Phase 1

Lymphoseek

Anal Cancer

PHASE_2

Clinical Trials (1)

NCT02857608A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus

Phase 2

Radiation therapy

Oropharynx Cancer

PHASE_2

Clinical Trials (1)

NCT05800574Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

Phase 2

Loxoprofen Pain Patch

Delayed Onset Muscle Soreness

PHASE_2

Clinical Trials (1)

NCT02602353Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)

Phase 2

Tc99m tilmanocept

Uterine Cervical Neoplasms

PHASE_2

Clinical Trials (1)

NCT02509585A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection

Phase 2

Tc99m tilmanocept

Rhabdomyosarcoma

PHASE_2

Clinical Trials (1)

NCT02509598A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping

Phase 2

Kyphoplasty

Osteoporotic Vertebral Compression Fractures

PHASE_3

Clinical Trials (1)

NCT00279877Cost Effectiveness and Efficacy of Kyphoplasty and Vertebroplasty Trial

Phase 3

Mynx Vascular Closure System

Cardiac Diagnostic Procedure

PHASE_4

Clinical Trials (1)

NCT02438475The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure

Phase 4

Interview Prep Quick Facts

Portfolio: 16 clinical trials

Top TAs: Oncology, Cardiovascular, Metabolic Diseases

Publications: 28 in PubMed

SEC Filings: 2 available

Open Roles: 743 active jobs

Therapeutic Area Focus

7 pipeline

1 pipeline

1 pipeline

1 pipeline

Marketed

Pipeline

Financials (FY2026)

Revenue

$226.8B11%

Net Income

$852M

Cash

$3.9B

Source: SEC 10-K Filing

Hiring Trend

Actively Hiring

743

Open Roles

+530

Added

-185

Filled/Removed

Based on last 4 crawl cycles

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab: A Panel Chart Review Study.

Oncology and therapy

2026

PMID:41886245

Real-world treatment patterns and outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL-AVA 3.5 study.

British journal of haematology

2026

PMID:42136034

Showing 5 of 10 publications

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Cardinal Health(CAH)

Should You Work at Cardinal Health?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Recent News · Cardinal Health(10)

Open Jobs (743)

Nurse, Individualized Care Nurse Care Manager

Director, Business Development - Specialty Pharmacy

Supervisor, Customer Service

Sr Transportation Analyst – Freight Pay & Audit

Interim Director of Pharmacy

Program Manager

Advisor, Facility and Security Technology

Sr Data Analyst – Supply Chain Analytics

Data Analyst, Data Analytics

Meeting Planner, Specialty Programs, Meetings & Events

Analyst, Pharmaceutical Inside Sales Representative

Supervisor, Access and Patient Support

Transportation Consultant – Data Analytics

Sr Analyst, Business Metrics/Analytics

Project lead, Implementation, OptiFreight Logistics

Sr.Coordinator, Quality Control

Kinaxis Engineer, Application Development and Maintenance

Manager, Security Engineering & Platforms

Sr. Coordinator Individualized Care

Senior Analyst, Revenue Cycle Management

Senior Salesforce Engineer

Bilingual Sr. Coordinator, Patient Access (Case Manager)

Sr. Coordinator, Individualized Care

Care Coordinator

Sr Specialist, Post Market Vigilance

Financials (FY2026)

Hiring Trend

Research Publications(10)